Hale David F - Jun 30, 2021 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Director
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Stock symbol
ONCT
Transactions as of
Jun 30, 2021
Transactions value $
-$17,428
Form type
4
Date filed
7/2/2021, 05:01 PM
Previous filing
May 27, 2021
Next filing
Jul 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Sale -$17.4K -3.67K -0.51% $4.75 713K Jun 30, 2021 By Hale BioPharma Ventures, LLC F1
holding ONCT Common Stock 18.3K Jun 30, 2021 By Hale Trading Company
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were transferred to Oxford Finance LLC by Hale BioPharma Ventures, LLC in satisfaction of a pledge by Hale BioPharma Ventures, LLC which was previously disclosed by the Issuer.